{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:54:47Z","timestamp":1787997287302,"version":"build-2784847793"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Contracept Reprod Med"],"DOI":"10.1186\/s40834-025-00368-1","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:22:08Z","timestamp":1758806528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal stem cells and platelet rich plasma in the treatment of premature ovarian insufficiency: a scoping review"],"prefix":"10.1186","volume":"10","author":[{"given":"Jack","family":"Gemayel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Tahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Younes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvanna","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Chaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Chebly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Akouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"2","key":"368_CR1","first-page":"51","volume":"16","author":"K Jankowska","year":"2017","unstructured":"Jankowska K. Premature ovarian failure. Prz Menopauzalny. 2017;16(2):51\u20136.","journal-title":"Prz Menopauzalny"},{"key":"368_CR2","doi-asserted-by":"publisher","unstructured":"Huang Y, Zhu M, Liu Z, Hu R, Li F, Song Y et al. Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects. Front Immunol. 2022 Oct 27 [cited 2023 May 11];13. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fimmu.2022.997808\/full","DOI":"10.3389\/fimmu.2022.997808\/full"},{"issue":"11\u201312","key":"368_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2298\/SARH1212806V","volume":"140","author":"S Vujovi\u0107","year":"2012","unstructured":"Vujovi\u0107 S, Ivovi\u0107 M, Tanci\u0107-Gaji\u0107 M, Marina L, Bara\u0107 M, Arizanovi\u0107 Z, et al. Premature ovarian failure. Srp Arh Celok Lek. 2012;140(11\u201312):806\u201311.","journal-title":"Srp Arh Celok Lek"},{"issue":"1","key":"368_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13048-021-00871-4","volume":"14","author":"X Lv","year":"2021","unstructured":"Lv X, Guan C, Li Y, Su X, Zhang L, Wang X, et al. Effects of single and multiple transplantations of human umbilical cord mesenchymal stem cells on the recovery of ovarian function in the treatment of premature ovarian failure in mice. J Ovarian Res. 2021;14(1):119.","journal-title":"J Ovarian Res"},{"issue":"2","key":"368_CR5","first-page":"54","volume":"5","author":"M Ebrahimi","year":"2011","unstructured":"Ebrahimi M, Akbari Asbagh F. Pathogenesis and causes of premature ovarian failure: an update. Int J Fertil Steril. 2011;5(2):54\u201365.","journal-title":"Int J Fertil Steril"},{"key":"368_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-1172-1-9","volume":"1","author":"P Beck-Peccoz","year":"2006","unstructured":"Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9.","journal-title":"Orphanet J Rare Dis"},{"key":"368_CR7","unstructured":"Sopiarz N, Sparzak PB. Primary Ovarian Insufficiency. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 13]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK589674\/"},{"issue":"9","key":"368_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s40618-016-0467-z","volume":"39","author":"A Podfigurna-Stopa","year":"2016","unstructured":"Podfigurna-Stopa A, Czyzyk A, Grymowicz M, Smolarczyk R, Katulski K, Czajkowski K, et al. Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest. 2016;39(9):983\u201390.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"368_CR9","first-page":"597","volume":"14","author":"A Ghadiri-Anari","year":"2016","unstructured":"Ghadiri-Anari A, Mortezaii-Shoroki Z, Modarresi M, Dehghan A. Association of lipid profile with bone mineral density in postmenopausal women in Yazd Province. Int J Reproductive Biomed. 2016;14(9):597\u2013602.","journal-title":"Int J Reproductive Biomed"},{"issue":"3","key":"368_CR10","first-page":"109","volume":"17","author":"A Podfigurna","year":"2018","unstructured":"Podfigurna A, M\u0119czekalski B. Cardiovascular health in patients with premature ovarian insufficiency. Management of long-term consequences. Prz Menopauzalny. 2018;17(3):109\u201311.","journal-title":"Prz Menopauzalny"},{"key":"368_CR11","unstructured":"MSD Manual Professional Edition. 2023 [cited 2023 May 11]. Primary Ovarian Insufficiency - Gynecology and Obstetrics. Available from: https:\/\/www.msdmanuals.com\/professional\/gynecology-and-obstetrics\/menstrual-abnormalities\/primary-ovarian-insufficiency"},{"key":"368_CR12","unstructured":"RACGP - Premature ovarian insufficiency in general practice. Meeting the needs of women. 2023 [cited 2023 May 11]. Available from: https:\/\/www.racgp.org.au\/afp\/2017\/june\/premature-ovarian-insufficiency-in-general-practic"},{"key":"368_CR13","unstructured":"Amenorrhea. Types, Causes, Symptoms, Diagnosis & Treatment. 2023 [cited 2023 May 11]. Available from: https:\/\/my.clevelandclinic.org\/health\/diseases\/3924-amenorrhea"},{"issue":"1","key":"368_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0015-0282(98)00099-5","volume":"70","author":"JN Anasti","year":"1998","unstructured":"Anasti JN. Premature ovarian failure: an update. Fertil Steril. 1998;70(1):1\u201315.","journal-title":"Fertil Steril"},{"key":"368_CR15","doi-asserted-by":"publisher","first-page":"601752","DOI":"10.3389\/fendo.2021.601752","volume":"12","author":"X Jiao","year":"2021","unstructured":"Jiao X, Meng T, Zhai Y, Zhao L, Luo W, Liu P, et al. Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies. Front Endocrinol (Lausanne). 2021;12:601752.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"368_CR16","doi-asserted-by":"crossref","unstructured":"Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve. Function in Patients with Premature Ovarian Insufficiency. 2023 [cited 2023 May 21]. Available from: https:\/\/www.hindawi.com\/journals\/bmri\/2022\/3878359\/","DOI":"10.1155\/2023\/9875072"},{"key":"368_CR17","first-page":"370195","volume":"2011","author":"S Baronchelli","year":"2011","unstructured":"Baronchelli S, Conconi D, Panzeri E, Bentivegna A, Redaelli S, Lissoni S, et al. Cytogenetics of premature ovarian failure: an investigation on 269 affected women. J Biomed Biotechnol. 2011;2011:370195.","journal-title":"J Biomed Biotechnol"},{"key":"368_CR18","unstructured":"Primary Ovarian Insufficiency in Adolescents and Young Women. 2023 [cited 2023 May 11]. Available from: https:\/\/www.acog.org\/en\/clinical\/clinical-guidance\/committee-opinion\/articles\/2014\/07\/primary-ovarian-insufficiency-in-adolescents-and-young-women"},{"issue":"sup2","key":"368_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/09513590.2016.1232676","volume":"32","author":"IG Shestakova","year":"2016","unstructured":"Shestakova IG, Radzinsky VE, Khamoshina MB. Occult form of premature ovarian insufficiency. Gynecol Endocrinol. 2016;32(sup2):30\u20132.","journal-title":"Gynecol Endocrinol"},{"key":"368_CR20","unstructured":"Ovarian Insufficiency Follow-up. Further Outpatient Care. 2023 [cited 2023 May 11]. Available from: https:\/\/emedicine.medscape.com\/article\/271046-followup?reg=1"},{"key":"368_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6874-3-2","volume":"3","author":"JA Novosad","year":"2003","unstructured":"Novosad JA, Kalantaridou SN, Tong ZB, Nelson LM. Ovarian antibodies as detected by indirect Immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health. 2003;3:2.","journal-title":"BMC Womens Health"},{"issue":"12","key":"368_CR22","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/humrep\/12.12.2617","volume":"12","author":"NJ Wheatcroft","year":"1997","unstructured":"Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by Immunofluorescence, enzyme-linked immunosorbent assay or Immunoblotting in premature ovarian failure. Hum Reprod. 1997;12(12):2617\u201322.","journal-title":"Hum Reprod"},{"key":"368_CR23","unstructured":"IMMUNOLOGICAL ASPECTS OF PREMATURE OVARIAN FAILURE ASSOCIATED WITH IDIOPATHIC ADDISON\u2019S. DISEASE - The Lancet. 2023 [cited 2023 May 11]. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(68)91053-2\/fulltext"},{"issue":"7","key":"368_CR24","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","volume":"106","author":"SD Sullivan","year":"2016","unstructured":"Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588\u201399.","journal-title":"Fertil Steril"},{"issue":"7","key":"368_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/jwh.2013.4611","volume":"23","author":"JM Kling","year":"2014","unstructured":"Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: A review. J Womens Health (Larchmt). 2014;23(7):563\u201372.","journal-title":"J Womens Health (Larchmt)"},{"key":"368_CR26","doi-asserted-by":"publisher","first-page":"174550651986400","DOI":"10.1177\/1745506519864009","volume":"15","author":"S Palacios","year":"2019","unstructured":"Palacios S, Stevenson JC, Schaudig K, Lukasiewicz M, Graziottin A. Hormone therapy for first-line management of menopausal symptoms: practical recommendations. Womens Health (Lond). 2019;15:1745506519864009.","journal-title":"Womens Health (Lond)"},{"issue":"2","key":"368_CR27","doi-asserted-by":"publisher","first-page":"hox007","DOI":"10.1093\/hropen\/hox007","volume":"2017","author":"L Webber","year":"2017","unstructured":"Webber L, Anderson RA, Davies M, Janse F, Vermeulen N. HRT for women with premature ovarian insufficiency: a comprehensive review. Hum Reprod Open. 2017;2017(2):hox007.","journal-title":"Hum Reprod Open"},{"key":"368_CR28","unstructured":"Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis - ScienceDirect. 2023 [cited 2023 May 11]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S1472648322000852"},{"issue":"6","key":"368_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/01.gme.0000184221.63459.e1","volume":"12","author":"NR Shah","year":"2005","unstructured":"Shah NR, Borenstein J, Dubois RW. Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis. Menopause. 2005;12(6):668\u201378.","journal-title":"Menopause"},{"issue":"10","key":"368_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jdcr.2019.08.015","volume":"5","author":"Q Thibodeaux","year":"2019","unstructured":"Thibodeaux Q, Ly K, Reddy V, Smith MP, Liao W. Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis. JAAD Case Rep. 2019;5(10):928\u201330.","journal-title":"JAAD Case Rep"},{"issue":"3","key":"368_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of Estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial. JAMA. 2002;288(3):321\u201333.","journal-title":"JAMA"},{"issue":"12","key":"368_CR32","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.3390\/jcm9123961","volume":"9","author":"A Podfigurna","year":"2020","unstructured":"Podfigurna A, Maciejewska-Jeske M, Nadolna M, Mikolajska-Ptas P, Szeliga A, Bilinski P, et al. Impact of hormonal replacement therapy on bone mineral density in premature ovarian insufficiency patients. J Clin Med. 2020;9(12):3961.","journal-title":"J Clin Med"},{"issue":"3","key":"368_CR33","first-page":"112","volume":"17","author":"A Szeliga","year":"2018","unstructured":"Szeliga A, Maciejewska-Jeske M, M\u0119czekalski B. Bone health and evaluation of bone mineral density in patients with premature ovarian insufficiency. Prz Menopauzalny. 2018;17(3):112\u20136.","journal-title":"Prz Menopauzalny"},{"issue":"9","key":"368_CR34","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1210\/jc.2013-4145","volume":"99","author":"VB Popat","year":"2014","unstructured":"Popat VB, Calis KA, Kalantaridou SN, Vanderhoof VH, Koziol D, Troendle JF, et al. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. J Clin Endocrinol Metab. 2014;99(9):3418\u201326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"368_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.fertnstert.2007.02.032","volume":"89","author":"VB Popat","year":"2008","unstructured":"Popat VB, Vanderhoof VH, Calis KA, Troendle JF, Nelson LM. Normalization of serum LH levels in women with 46,XX spontaneous primary ovarian insufficiency. Fertil Steril. 2008;89(2):429\u201333.","journal-title":"Fertil Steril"},{"issue":"1","key":"368_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/humrep\/del337","volume":"22","author":"A Allegra","year":"2007","unstructured":"Allegra A, Marino A, Coffaro F, Scaglione P, Sammartano F, Rizza G, et al. GnRH antagonist-induced Inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Hum Reprod. 2007;22(1):101\u20138.","journal-title":"Hum Reprod"},{"issue":"3","key":"368_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0974-1208.192053","volume":"9","author":"S Jain","year":"2016","unstructured":"Jain S, Majumdar A. Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles. J Hum Reprod Sci. 2016;9(3):151\u20138.","journal-title":"J Hum Reprod Sci"},{"key":"368_CR38","doi-asserted-by":"crossref","unstructured":"Huang Q, yi, Chen S, rong, Chen J ming, Shi Q yang, Lin S. Therapeutic options for premature ovarian insufficiency: an updated review. Reprod Biol Endocrinol. 2022;20:28.","DOI":"10.1186\/s12958-022-00892-8"},{"issue":"5","key":"368_CR39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.fertnstert.2018.01.020","volume":"109","author":"MJ Liu","year":"2018","unstructured":"Liu MJ, Sun AG, Zhao SG, Liu H, Ma SY, Li M, et al. Resveratrol improves in vitro maturation of oocytes in aged mice and humans. Fertil Steril. 2018;109(5):900\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"368_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/humrep\/des437","volume":"28","author":"M Liu","year":"2013","unstructured":"Liu M, Yin Y, Ye X, Zeng M, Zhao Q, Keefe DL, et al. Resveratrol protects against age-associated infertility in mice. Hum Reprod. 2013;28(3):707\u201317.","journal-title":"Hum Reprod"},{"issue":"2","key":"368_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/rmb2.12303","volume":"19","author":"A Ochiai","year":"2020","unstructured":"Ochiai A, Kuroda K. Preconception Resveratrol intake against infertility: friend or foe? Reprod Med Biol. 2020;19(2):107\u201313.","journal-title":"Reprod Med Biol"},{"issue":"5","key":"368_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10815-018-1159-8","volume":"35","author":"A Bos-Mikich","year":"2018","unstructured":"Bos-Mikich A, de Oliveira R, Frantz N. Platelet-rich plasma therapy and reproductive medicine. J Assist Reprod Genet. 2018;35(5):753\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"368_CR43","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/jcm9061809","volume":"9","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Simopoulou M, Grigoriadis S, Pantou A, Tsioulou P, Maziotis E, et al. Reactivating ovarian function through autologous Platelet-Rich plasma intraovarian infusion: pilot data on premature ovarian insufficiency, perimenopausal, menopausal, and poor responder women. J Clin Med. 2020;9(6):1809.","journal-title":"J Clin Med"},{"issue":"4","key":"368_CR44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.rbmo.2017.04.007","volume":"35","author":"L Hosseini","year":"2017","unstructured":"Hosseini L, Shirazi A, Naderi MM, Shams-Esfandabadi N, Borjian Boroujeni S, Sarvari A, et al. Platelet-rich plasma promotes the development of isolated human primordial and primary follicles to the preantral stage. Reprod Biomed Online. 2017;35(4):343\u201350.","journal-title":"Reprod Biomed Online"},{"key":"368_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12958-020-00638-4","volume":"18","author":"S Ahmadian","year":"2020","unstructured":"Ahmadian S, Sheshpari S, Pazhang M, Bedate AM, Beheshti R, Abbasi MM, et al. Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation. Reprod Biol Endocrinol. 2020;18:78.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"368_CR46","first-page":"147","volume":"6","author":"AJ Fenton","year":"2015","unstructured":"Fenton AJ. Premature ovarian insufficiency: pathogenesis and management. J Midlife Health. 2015;6(4):147\u201353.","journal-title":"J Midlife Health"},{"issue":"9744","key":"368_CR47","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","volume":"376","author":"M De Vos","year":"2010","unstructured":"De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376(9744):911\u201321.","journal-title":"Lancet"},{"issue":"3","key":"368_CR48","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/GCO.0000000000000268","volume":"28","author":"K Kawamura","year":"2016","unstructured":"Kawamura K, Kawamura N, Hsueh AJW. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016;28(3):217\u201322.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"368_CR49","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms22073785","volume":"22","author":"KCT Vo","year":"2021","unstructured":"Vo KCT, Kawamura K. Vitro activation early follicles: from the basic science to the clinical perspectives. Int J Mol Sci. 2021;22(7):3785.","journal-title":"Int J Mol Sci"},{"key":"368_CR50","doi-asserted-by":"publisher","unstructured":"Piedade KC, Spencer H, Persani L, Nelson LM. Optimizing Fertility in Primary Ovarian Insufficiency: Case Report and Literature Review. Frontiers in Genetics. 2021 [cited 2023 May 12];12. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fgene.2021.676262","DOI":"10.3389\/fgene.2021.676262"},{"key":"368_CR51","unstructured":"Choe J, Shanks AL. In Vitro Fertilization. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 12]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562266\/"},{"issue":"1","key":"368_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/biomedicines7010002","volume":"7","author":"JJ Chae-Kim","year":"2018","unstructured":"Chae-Kim JJ, Gavrilova-Jordan L. Premature ovarian insufficiency: procreative management and preventive strategies. Biomedicines. 2018;7(1):2.","journal-title":"Biomedicines"},{"key":"368_CR53","unstructured":"H B, R D, F E, J K, A M, R S, et al. Update on ovarian hyperstimulation syndrome: Part 1\u2013Incidence and pathogenesis. International journal of fertility and women\u2019s medicine. 2007 Feb [cited 2023 May 12];52(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17987884\/"},{"key":"368_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1477-7827-8-31","volume":"8","author":"ES Sills","year":"2010","unstructured":"Sills ES, Brady AC, Omar AB, Walsh DJ, Salma U, Walsh AP. IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister. Reprod Biol Endocrinol. 2010;8:31.","journal-title":"Reprod Biol Endocrinol"},{"key":"368_CR55","doi-asserted-by":"crossref","unstructured":"Ishizuka B, Furuya M, Kimura M, Kamioka E, Kawamura K. Live Birth Rate in Patients With Premature Ovarian Insufficiency During Long-Term Follow-Up Under Hormone Replacement With or Without Ovarian Stimulation. Frontiers in Endocrinology. 2021 [cited 2023 May 12];12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8719621\/","DOI":"10.3389\/fendo.2021.795724"},{"key":"368_CR56","unstructured":"www.MeDitorial.cz. Specifics of infertility treatment in women with prematur.. 2023 [cited 2023 May 13]. Available from: https:\/\/www.prolekare.cz\/en\/journals\/czech-gynaecology\/2023-2-5\/specifics-of-infertility-treatment-in-women-with-premature-ovarian-failure-134071"},{"key":"368_CR57","doi-asserted-by":"crossref","unstructured":"Wesevich V, Kellen AN, Pal L. Recent advances in understanding primary ovarian insufficiency. F1000Research; 2020 [cited 2023 May 13]. Available from: https:\/\/f1000research.com\/articles\/9-1101","DOI":"10.12688\/f1000research.26423.1"},{"issue":"2","key":"368_CR58","first-page":"95","volume":"31","author":"JS Baek","year":"2018","unstructured":"Baek JS. A clinical study on one case of a spontaneous pregnancy with premature ovarian failure. J Korean Obstet Gynecol. 2018;31(2):95\u2013102.","journal-title":"J Korean Obstet Gynecol"},{"key":"368_CR59","unstructured":"Spontaneous pregnancy in a patient with premature ovarian insufficiency\u2013 case report - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6196780\/#cit0002"},{"key":"368_CR60","doi-asserted-by":"publisher","unstructured":"Chon SJ, Umair Z, Yoon MS. Premature Ovarian Insufficiency: Past, Present, and Future. Frontiers in Cell and Developmental Biology. 2021 [cited 2023 May 13];9. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcell.2021.672890","DOI":"10.3389\/fcell.2021.672890"},{"key":"368_CR61","unstructured":"Primary Ovarian Insufficiency - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2762081\/"},{"issue":"6","key":"368_CR62","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(95)90275-9","volume":"82","author":"K Aittom\u00e4ki","year":"1995","unstructured":"Aittom\u00e4ki K, Dieguez Lucena J, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959\u201368.","journal-title":"Cell"},{"issue":"4","key":"368_CR63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0300-1652.107549","volume":"53","author":"P Kumar","year":"2012","unstructured":"Kumar P, Magon N. Hormones in pregnancy. Niger Med J. 2012;53(4):179\u201383.","journal-title":"Niger Med J"},{"issue":"7","key":"368_CR64","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/ijms21072592","volume":"21","author":"M Mandal\u00e0","year":"2020","unstructured":"Mandal\u00e0 M. Influence of estrogens on uterine vascular adaptation in normal and preeclamptic pregnancies. Int J Mol Sci. 2020;21(7):2592.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"368_CR65","first-page":"1","volume":"8","author":"F Pouresmaeili","year":"2014","unstructured":"Pouresmaeili F, Fazeli Z. Premature ovarian failure: A critical condition in the reproductive potential with various genetic causes. Int J Fertil Steril. 2014;8(1):1\u201312.","journal-title":"Int J Fertil Steril"},{"key":"368_CR66","unstructured":"Genetics of human female infertility - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8127036\/"},{"issue":"8","key":"368_CR67","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1210\/endo.140.8.7046","volume":"140","author":"MH Melner","year":"1999","unstructured":"Melner MH, Feltus FA. Editorial: autoimmune premature ovarian Failure\u2014Endocrine aspects of a T cell disease**. Endocrinology. 1999;140(8):3401\u20133.","journal-title":"Endocrinology"},{"issue":"3","key":"368_CR68","first-page":"125","volume":"19","author":"Z Rajabi","year":"2018","unstructured":"Rajabi Z, Aliakbari F, Yazdekhasti H. Female fertility preservation, clinical and experimental options. J Reprod Infertil. 2018;19(3):125\u201332.","journal-title":"J Reprod Infertil"},{"issue":"5","key":"368_CR69","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2165\/00002018-200528050-00004","volume":"28","author":"JR Molina","year":"2005","unstructured":"Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005;28(5):401\u201316.","journal-title":"Drug Saf"},{"issue":"1","key":"368_CR70","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12958-021-00884-0","volume":"20","author":"Z Walker","year":"2022","unstructured":"Walker Z, Lanes A, Ginsburg E. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Reproductive Biology Endocrinol. 2022;20(1):10.","journal-title":"Reproductive Biology Endocrinol"},{"issue":"3","key":"368_CR71","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/humupd\/dmh021","volume":"10","author":"M Sonmezer","year":"2004","unstructured":"Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10(3):251\u201366.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"368_CR72","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jpag.2015.10.011","volume":"29","author":"K Oktay","year":"2016","unstructured":"Oktay K, Bedoschi G, Berkowitz K, Bronson R, Kashani B, McGovern P, et al. Fertility preservation in females with Turner syndrome: A comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2016;29(5):409\u201316.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"368_CR73","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jpag.2014.01.003","volume":"27","author":"K Oktay","year":"2014","unstructured":"Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J Pediatr Adolesc Gynecol. 2014;27(6):342\u20136.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"368_CR74","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/humupd\/dmq010","volume":"16","author":"P Jadoul","year":"2010","unstructured":"Jadoul P, Dolmans MM, Donnez J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update. 2010;16(6):617\u201330.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"368_CR75","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1470-2045(14)70334-1","volume":"15","author":"WHB Wallace","year":"2014","unstructured":"Wallace WHB, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15(10):1129\u201336.","journal-title":"Lancet Oncol"},{"issue":"3","key":"368_CR76","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/humrep\/del440","volume":"22","author":"M S\u00e1nchez","year":"2007","unstructured":"S\u00e1nchez M, Alam\u00e1 P, Gadea B, Soares SR, Sim\u00f3n C, Pellicer A. Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod. 2007;22(3):786\u201391.","journal-title":"Hum Reprod"},{"issue":"10","key":"368_CR77","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1055\/s-0032-1327812","volume":"72","author":"V Isachenko","year":"2012","unstructured":"Isachenko V, Dittrich R, Keck G, Isachenko E, van der Rahimi G, et al. Cryopreservation of ovarian tissue: detailed description of methods for transport, freezing and thawing. Geburtshilfe Frauenheilkd. 2012;72(10):927\u201332.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"10","key":"368_CR78","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1089\/jwh.2010.2625","volume":"20","author":"J Hirshfeld-Cytron","year":"2011","unstructured":"Hirshfeld-Cytron J, Gracia C, Woodruff TK. Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation. J Womens Health (Larchmt). 2011;20(10):1467\u201377.","journal-title":"J Womens Health (Larchmt)"},{"issue":"34","key":"368_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jncimonographs\/lgi014","volume":"2005","author":"JE Roberts","year":"2005","unstructured":"Roberts JE, Oktay K. Fertility preservation: A comprehensive approach to the young woman with Cancer. JNCI Monogr. 2005;2005(34):57\u20139.","journal-title":"JNCI Monogr"},{"issue":"6","key":"368_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3109\/07853890.2010.546807","volume":"43","author":"J Donnez","year":"2011","unstructured":"Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med. 2011;43(6):437\u201350.","journal-title":"Ann Med"},{"issue":"2","key":"368_CR81","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/bit.22250","volume":"103","author":"M Xu","year":"2009","unstructured":"Xu M, Banc A, Woodruff TK, Shea LD. Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles. Biotechnol Bioeng. 2009;103(2):378\u201386.","journal-title":"Biotechnol Bioeng"},{"issue":"3","key":"368_CR82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/humrep\/deu353","volume":"30","author":"N Suzuki","year":"2015","unstructured":"Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30(3):608\u201315.","journal-title":"Hum Reprod"},{"issue":"3","key":"368_CR83","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.fertnstert.2017.05.024","volume":"108","author":"F Martinez","year":"2017","unstructured":"Martinez F, International Society for Fertility Preservation\u2013ESHRE\u2013ASRM Expert Working Group. Update on fertility preservation from the Barcelona international society for fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017;108(3):407\u2013e41511.","journal-title":"Fertil Steril"},{"issue":"8","key":"368_CR84","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10815-015-0507-1","volume":"32","author":"L Rienzi","year":"2015","unstructured":"Rienzi L, Ubaldi FM. Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women\u2019s autonomy. J Assist Reprod Genet. 2015;32(8):1195\u20136.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"368_CR85","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5152\/jtgga.2014.0022","volume":"15","author":"YE \u015e\u00fck\u00fcr","year":"2014","unstructured":"\u015e\u00fck\u00fcr YE, K\u0131van\u00e7l\u0131 \u0130B, \u00d6zmen B. Ovarian aging and premature ovarian failure. J Turk Ger Gynecol Assoc. 2014;15(3):190\u20136.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"3","key":"368_CR86","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000499054","volume":"46","author":"EC Rivas Leonel","year":"2019","unstructured":"Rivas Leonel EC, Lucci CM, Amorim CA. Cryopreservation of human ovarian tissue: A review. Transfus Med Hemother. 2019;46(3):173\u201381.","journal-title":"Transfus Med Hemother"},{"key":"368_CR87","doi-asserted-by":"crossref","unstructured":"Je CM, Cd M, Sm B, Lm E, Nt M. C, Fertility Preservation and Financial Hardship among Adolescent and Young Adult Women with Cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2022 May 4 [cited 2023 May 13];31(5). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35506248\/","DOI":"10.1158\/1055-9965.EPI-21-1305"},{"issue":"2","key":"368_CR88","doi-asserted-by":"publisher","first-page":"e00191","DOI":"10.1042\/BSR20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.","journal-title":"Biosci Rep"},{"issue":"3","key":"368_CR89","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.18295\/squmj.2018.18.03.002","volume":"18","author":"R Berebichez-Fridman","year":"2018","unstructured":"Berebichez-Fridman R, Montero-Olvera PR. Sources and clinical applications of mesenchymal stem cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2018;18(3):e264\u2013277.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"368_CR90","doi-asserted-by":"publisher","first-page":"602647","DOI":"10.3389\/fcell.2020.602647","volume":"8","author":"A Coelho","year":"2020","unstructured":"Coelho A, Alvites RD, Branquinho MV, Guerreiro SG, Maur\u00edcio AC. Mesenchymal stem cells (MSCs) as a potential therapeutic strategy in COVID-19 patients: literature research. Front Cell Dev Biol. 2020;8:602647.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"368_CR91","first-page":"208","volume":"10","author":"K Baghaei","year":"2017","unstructured":"Baghaei K, Hashemi SM, Tokhanbigli S, Asadi Rad A, Assadzadeh-Aghdaei H, Sharifian A, et al. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. Gastroenterol Hepatol Bed Bench. 2017;10(3):208\u201313.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"368_CR92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Blanc KL, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"6","key":"368_CR93","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/ten.teb.2016.0365","volume":"23","author":"Y Fu","year":"2017","unstructured":"Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev. 2017;23(6):515\u201328.","journal-title":"Tissue Eng Part B Rev"},{"key":"368_CR94","doi-asserted-by":"publisher","unstructured":"Pankajakshan D, Agrawal DK. Mesenchymal stem cell paracrine factors in vascular repair and regeneration. J Biomed Technol Res. 2014;1(1). https:\/\/doi.org\/10.19104\/jbtr.2014.107","DOI":"10.19104\/jbtr.2014.107"},{"issue":"19","key":"368_CR95","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.3390\/ijms21197038","volume":"21","author":"P Ahangar","year":"2020","unstructured":"Ahangar P, Mills SJ, Cowin AJ. Mesenchymal stem cell secretome as an emerging cell-Free alternative for improving wound repair. Int J Mol Sci. 2020;21(19):7038.","journal-title":"Int J Mol Sci"},{"key":"368_CR96","unstructured":"Antimicrobial Activity of Mesenchymal Stem Cells. Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5371613\/"},{"issue":"6","key":"368_CR97","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/genes13060949","volume":"13","author":"V Molnar","year":"2022","unstructured":"Molnar V, Paveli\u0107 E, Vrdoljak K, \u010cemerin M, Klari\u0107 E, Mati\u0161i\u0107 V, et al. Mesenchymal stem cell mechanisms of action and clinical effects in osteoarthritis: A narrative review. Genes (Basel). 2022;13(6):949.","journal-title":"Genes (Basel)"},{"key":"368_CR98","unstructured":"Immunomodulatory Effects of MSCs in Bone Healing - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6862454\/"},{"issue":"3","key":"368_CR99","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jcp.21701","volume":"219","author":"R ESTRADA","year":"2009","unstructured":"ESTRADA R, LI N, SAROJINI H, AN J, LEE MJ. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol. 2009;219(3):563\u201371.","journal-title":"J Cell Physiol"},{"key":"368_CR100","unstructured":"Development of secretome-based strategies to improve cell culture protocols in tissue engineering| Scientific Reports. [cited 2025 Jan 8]. Available from: https:\/\/www.nature.com\/articles\/s41598-022-14115-y"},{"key":"368_CR101","doi-asserted-by":"crossref","unstructured":"M\u0171zes G, Sipos F. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases. Cells. 2022 Jul 26 [cited 2024 Feb 15];11(15):2300. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9367576\/","DOI":"10.3390\/cells11152300"},{"key":"368_CR102","unstructured":"Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program - PubMed. 2023 [cited 2023 May 13]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20958294\/"},{"issue":"3","key":"368_CR103","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.it.2011.11.004","volume":"33","author":"Y Shi","year":"2012","unstructured":"Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 2012;33(3):136\u201343.","journal-title":"Trends Immunol"},{"key":"368_CR104","doi-asserted-by":"publisher","unstructured":"Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Research & Therapy. 2021 Oct 18 [cited 2025 Feb 19];12(1):545. Available from: https:\/\/doi.org\/10.1186\/s13287-021-02609-x","DOI":"10.1186\/s13287-021-02609-x"},{"key":"368_CR105","doi-asserted-by":"publisher","unstructured":"Zhuang WZ, Lin YH, Su LJ, Wu MS, Jeng HY, Chang HC et al. Mesenchymal stem\/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. Journal of Biomedical Science. 2021 Apr 14 [cited 2025 Feb 19];28(1):28. Available from: https:\/\/doi.org\/10.1186\/s12929-021-00725-7","DOI":"10.1186\/s12929-021-00725-7"},{"issue":"1","key":"368_CR106","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/096368910X","volume":"20","author":"DC Ding","year":"2011","unstructured":"Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. Cell Transpl. 2011;20(1):5\u201314.","journal-title":"Cell Transpl"},{"issue":"2","key":"368_CR107","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jcb.22399","volume":"109","author":"M Ohishi","year":"2010","unstructured":"Ohishi M, Schipani E. Bone marrow mesenchymal stem cells. J Cell Biochem. 2010;109(2):277\u201382.","journal-title":"J Cell Biochem"},{"issue":"5","key":"368_CR108","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","volume":"24","author":"S Kern","year":"2006","unstructured":"Kern S, Eichler H, Stoeve J, Kl\u00fcter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006;24(5):1294\u2013301.","journal-title":"Stem Cells"},{"issue":"9","key":"368_CR109","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4252\/wjsc.v10.i9.116","volume":"10","author":"ME Grawish","year":"2018","unstructured":"Grawish ME. Gingival-derived mesenchymal stem cells: an endless resource for regenerative dentistry. World J Stem Cells. 2018;10(9):116\u20138.","journal-title":"World J Stem Cells"},{"issue":"3","key":"368_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/096368915X686841","volume":"24","author":"DC Ding","year":"2015","unstructured":"Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: A new era for stem cell therapy. Cell Transpl. 2015;24(3):339\u201347.","journal-title":"Cell Transpl"},{"issue":"2","key":"368_CR111","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1471-0528.2008.02005.x","volume":"116","author":"L Gucciardo","year":"2009","unstructured":"Gucciardo L, Lories R, Ochsenbein-K\u00f6lble N, Done\u2019 E, Zwijsen A, Deprest J. Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG. 2009;116(2):166\u201372.","journal-title":"BJOG"},{"key":"368_CR112","unstructured":"Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome - PMC. [cited 2025 Jan 8]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11331624\/"},{"key":"368_CR113","unstructured":"Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment. A Systematic Review - PMC. [cited 2025 Jan 8]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9864810\/"},{"key":"368_CR114","doi-asserted-by":"crossref","unstructured":"Zhao Y, xia, Chen S, rong, Su P, ping, Huang F huang, Shi Y, chuan, Shi Q et al. yang,. Using Mesenchymal Stem Cells to Treat Female Infertility: An Update on Female Reproductive Diseases. Stem Cells Int. 2019;2019:9071720.","DOI":"10.1155\/2019\/9071720"},{"key":"368_CR115","unstructured":"Mesenchymal Stem Cells in Premature Ovarian Insufficiency. Mechanisms and Prospects - PMC. 2023 [cited 2023 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8369507\/"},{"key":"368_CR116","doi-asserted-by":"publisher","unstructured":"Harman RM, Van de Marx C. Translational Animal Models Provide Insight Into Mesenchymal Stromal Cell (MSC) Secretome Therapy. Frontiers in Cell and Developmental Biology. 2021 [cited 2023 May 11];9. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fcell.2021.654885","DOI":"10.3389\/fcell.2021.654885"},{"key":"368_CR117","unstructured":"Review of the Potential Therapeutic Effects and Molecular Mechanisms of Resveratrol on Endometriosis - PMC. 2023 [cited 2023 May 21]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10187648\/"},{"key":"368_CR118","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-018-1101-0","volume":"10","author":"Z Yan","year":"2019","unstructured":"Yan Z, Guo F, Yuan Q, Shao Y, Zhang Y, Wang H, et al. Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the expression of Gadd45b in cell cycle pathway. Stem Cell Res Ther. 2019;10:4.","journal-title":"Stem Cell Res Ther"},{"key":"368_CR119","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13287-021-02479-3","volume":"12","author":"EY Shin","year":"2021","unstructured":"Shin EY, Kim DS, Lee MJ, Lee AR, Shim SH, Baek SW, et al. Prevention of chemotherapy-induced premature ovarian insufficiency in mice by scaffold-based local delivery of human embryonic stem cell-derived mesenchymal progenitor cells. Stem Cell Res Ther. 2021;12:431.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"368_CR120","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4252\/wjsc.v12.i4.277","volume":"12","author":"J Shen","year":"2020","unstructured":"Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells. 2020;12(4):277\u201387.","journal-title":"World J Stem Cells"},{"issue":"1","key":"368_CR121","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13287-018-0964-4","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Wang Q, Li X, Wang Q, Xie J, Fu X. Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2018;9(1):240.","journal-title":"Stem Cell Res Ther"},{"key":"368_CR122","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-019-1327-5","volume":"10","author":"Z Yang","year":"2019","unstructured":"Yang Z, Du X, Wang C, Zhang J, Liu C, Li Y, et al. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice. Stem Cell Res Ther. 2019;10:250.","journal-title":"Stem Cell Res Ther"},{"key":"368_CR123","doi-asserted-by":"publisher","first-page":"718192","DOI":"10.3389\/fcell.2021.718192","volume":"9","author":"Z Li","year":"2021","unstructured":"Li Z, Zhang M, Tian Y, Li Q, Huang X. Mesenchymal stem cells in premature ovarian insufficiency: mechanisms and prospects. Front Cell Dev Biol. 2021;9:718192.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"368_CR124","doi-asserted-by":"publisher","first-page":"e2001689","DOI":"10.1002\/adhm.202001689","volume":"10","author":"C Chang","year":"2021","unstructured":"Chang C, Yan J, Yao Z, Zhang C, Li X, Mao HQ. Effects of mesenchymal stem Cell-Derived paracrine signals and their delivery strategies. Adv Healthc Mater. 2021;10(7):e2001689.","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"368_CR125","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/humrep\/deab106","volume":"36","author":"L Atkinson","year":"2021","unstructured":"Atkinson L, Martin F, Sturmey RG. Intraovarian injection of platelet-rich plasma in assisted reproduction: too much too soon? Hum Reprod. 2021;36(7):1737\u201350.","journal-title":"Hum Reprod"},{"issue":"20","key":"368_CR126","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.3390\/ijms21207794","volume":"21","author":"P Everts","year":"2020","unstructured":"Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-Rich plasma: new performance Understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794.","journal-title":"Int J Mol Sci"},{"issue":"47","key":"368_CR127","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1073\/pnas.1508520112","volume":"112","author":"AS Mao","year":"2015","unstructured":"Mao AS, Mooney DJ. Regenerative medicine: current therapies and future directions. Proc Natl Acad Sci U S A. 2015;112(47):14452\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"368_CR128","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2014.00123","volume":"5","author":"RT Kendall","year":"2014","unstructured":"Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123.","journal-title":"Front Pharmacol"},{"key":"368_CR129","doi-asserted-by":"publisher","unstructured":"Polonio AM, Garc\u00eda-Velasco JA, Herraiz S. Stem Cell Paracrine Signaling for Treatment of Premature Ovarian Insufficiency. Frontiers in Endocrinology. 2021 [cited 2023 May 13];11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fendo.2020.626322","DOI":"10.3389\/fendo.2020.626322"},{"key":"368_CR130","doi-asserted-by":"publisher","first-page":"096368972092615","DOI":"10.1177\/0963689720926154","volume":"29","author":"K Sfakianoudis","year":"2020","unstructured":"Sfakianoudis K, Rapani A, Grigoriadis S, Retsina D, Maziotis E, Tsioulou P, et al. Novel approaches in addressing ovarian insufficiency in 2019: are we there yet?? Cell Transpl. 2020;29:0963689720926154.","journal-title":"Cell Transpl"},{"issue":"9\u201310","key":"368_CR131","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1177\/0963689719859539","volume":"28","author":"K Pantos","year":"2019","unstructured":"Pantos K, Simopoulou M, Pantou A, Rapani A, Tsioulou P, Nitsos N, et al. A case series on natural conceptions resulting in ongoing pregnancies in menopausal and prematurely menopausal women following Platelet-Rich plasma treatment. Cell Transpl. 2019;28(9\u201310):1333\u201340.","journal-title":"Cell Transpl"},{"issue":"11","key":"368_CR132","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/aging.103403","volume":"12","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 2020;12(11):10211\u201322.","journal-title":"Aging"},{"issue":"12","key":"368_CR133","first-page":"e12037","volume":"12","author":"SR Panda","year":"2020","unstructured":"Panda SR, Sachan S, Hota S. A systematic review evaluating the efficacy of Intra-Ovarian infusion of autologous Platelet-Rich plasma in patients with poor ovarian reserve or ovarian insufficiency. Cureus. 2020;12(12):e12037.","journal-title":"Cureus"},{"key":"368_CR134","doi-asserted-by":"crossref","unstructured":"Fraidakis M, Giannakakis G, Anifantaki A, Skouradaki M, Tsakoumi P, Bitzopoulou P et al. Intraovarian Platelet-Rich Plasma Injections: Safety and Thoughts on Efficacy Based on a Single Centre Experience With 469 Women. Cureus. 2023 May 7 [cited 2023 May 13];15(5). Available from: https:\/\/www.cureus.com\/articles\/146008-intraovarian-platelet-rich-plasma-injections-safety-and-thoughts-on-efficacy-based-on-a-single-centre-experience-with-469-women","DOI":"10.7759\/cureus.38674"},{"key":"368_CR135","unstructured":"Jerin V, Neema A, Platelet-Rich Plasma. A Promising Regenerative Therapy in Gynecological Disorders. 2022 [cited 2023 May 13]; Available from: https:\/\/www.proquest.com\/docview\/2730488178"},{"issue":"7","key":"368_CR136","first-page":"1957","volume":"6","author":"S Zhang","year":"2020","unstructured":"Zhang S, Zhu D, Mei X, Li Z, Li J, Xie M, et al. Advances in biomaterials and regenerative medicine for primary ovarian insufficiency therapy. Bioact Mater. 2020;6(7):1957\u201372.","journal-title":"Bioact Mater"},{"issue":"32","key":"368_CR137","doi-asserted-by":"publisher","first-page":"e30013","DOI":"10.1097\/MD.0000000000030013","volume":"101","author":"L Shi","year":"2022","unstructured":"Shi L, Zhang Z, Deng M, Zheng F, Liu W, Ye S. Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure. Med (Baltim). 2022;101(32):e30013.","journal-title":"Med (Baltim)"},{"issue":"1","key":"368_CR138","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13287-021-02212-0","volume":"12","author":"YX Fu","year":"2021","unstructured":"Fu YX, Ji J, Shan F, Li J, Hu R. Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities. Stem Cell Res Ther. 2021;12(1):161.","journal-title":"Stem Cell Res Ther"},{"key":"368_CR139","doi-asserted-by":"crossref","unstructured":"Link to external site this link will open in a new window. Restoration of fertility in patients with spontaneous premature ovarian insufficiency: New Techniques under the Microscope. 2021;5647.","DOI":"10.3390\/jcm10235647"},{"issue":"1","key":"368_CR140","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11136-019-02326-2","volume":"29","author":"XT Li","year":"2020","unstructured":"Li XT, Li PY, Liu Y, Yang HS, He LY, Fang YG, et al. Health-related quality-of-life among patients with premature ovarian insufficiency: a systematic review and meta-analysis. Qual Life Res. 2020;29(1):19\u201336.","journal-title":"Qual Life Res"},{"issue":"3","key":"368_CR141","first-page":"135","volume":"17","author":"P Machura","year":"2018","unstructured":"Machura P, Grymowicz M, Rudnicka E, Pi\u0119ta W, Calik-Ksepka A, Sk\u00f3rska J, et al. Premature ovarian insufficiency - hormone replacement therapy and management of long-term consequences. Prz Menopauzalny. 2018;17(3):135\u20138.","journal-title":"Prz Menopauzalny"},{"issue":"9","key":"368_CR142","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10815-009-9351-5","volume":"26","author":"D Ameratunga","year":"2009","unstructured":"Ameratunga D, Weston G, Osianlis T, Catt J, Vollenhoven B. In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? J Assist Reprod Genet. 2009;26(9):511\u20134.","journal-title":"J Assist Reprod Genet"},{"key":"368_CR143","doi-asserted-by":"publisher","first-page":"e9053930","DOI":"10.1155\/2022\/9053930","volume":"2022","author":"Y Fu","year":"2022","unstructured":"Fu Y, Ding DN, Shen Y, Jia LY, Yan MY, Wei W, et al. Complementary and alternative medicine for premature ovarian insufficiency: A review of utilization and mechanisms. Evidence-Based Complement Altern Med. 2022;2022:e9053930.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"368_CR144","doi-asserted-by":"crossref","unstructured":"Gemayel J, Chaker D, El Hachem G, Mhanna M, Salemeh R, Hanna C, et al. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clin Transl Oncol. 2023;25(7):2056\u201368.","DOI":"10.1007\/s12094-023-03115-7"},{"key":"368_CR145","doi-asserted-by":"publisher","unstructured":"Hsu CC, Hsu L, Hsu I, Chiu YJ, Dorjee S. Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report. Frontiers in Endocrinology. 2020 [cited 2023 May 13];11. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fendo.2020.00050","DOI":"10.3389\/fendo.2020.00050"},{"key":"368_CR146","doi-asserted-by":"publisher","first-page":"912648","DOI":"10.3389\/fendo.2022.912648","volume":"13","author":"M Liu","year":"2022","unstructured":"Liu M, Li W, Zhou X, Zhou M, Zhang W, Liu Q, et al. Cell-Free fat extract improves ovarian function and fertility in mice with advanced age. Front Endocrinol (Lausanne). 2022;13:912648.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"368_CR147","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.NPR.0000660356.18430.0a","volume":"45","author":"A Thable","year":"2020","unstructured":"Thable A, Duff E, Dika C. Infertility management in primary care. Nurse Pract. 2020;45(5):48\u201354.","journal-title":"Nurse Pract"},{"key":"368_CR148","doi-asserted-by":"publisher","first-page":"1113684","DOI":"10.3389\/fphys.2023.1113684","volume":"14","author":"T Zhang","year":"2023","unstructured":"Zhang T, He M, Zhang J, Tong Y, Chen T, Wang C, et al. Mechanisms of primordial follicle activation and new pregnancy opportunity for premature ovarian failure patients. Front Physiol. 2023;14:1113684.","journal-title":"Front Physiol"}],"container-title":["Contraception and Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40834-025-00368-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40834-025-00368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:04:34Z","timestamp":1758809074000},"score":1,"resource":{"primary":{"URL":"https:\/\/contraceptionmedicine.biomedcentral.com\/articles\/10.1186\/s40834-025-00368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["368"],"URL":"https:\/\/doi.org\/10.1186\/s40834-025-00368-1","relation":{},"ISSN":["2055-7426"],"issn-type":[{"value":"2055-7426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}